The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Folfirinox versus gemcitabine/nab-paclitaxel for neoadjuvant treatment of resectable and borderline resectable pancreatic adenocarcinoma: A propensity matched analysis.
 
Mashaal Dhir
No Relationships to Disclose
 
Mazen S Zenati
No Relationships to Disclose
 
Ahmad Hamad
No Relationships to Disclose
 
Aatur D. Singhi
No Relationships to Disclose
 
Nathan Bahary
Consulting or Advisory Role - Bayer/Onyx; Celgene; EMD Serono
Research Funding - Newlink Genetics
 
Melissa Ellen Hogg
No Relationships to Disclose
 
Herbert Zeh
Research Funding - Aduro Biotech (Inst)
 
Amer H. Zureikat
No Relationships to Disclose